Insulin Syringes Market Size, Share, Trends, Growth Outlook

Insulin Syringes Market is estimated to increase at a growth rate of 4.6% CAGR over the forecast period from 2024 to 2030.

The global Insulin Syringes Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Syringe Size ( 3/10 CC Syringe (0.3ml), 1/2 CC Syringe (0.5ml), 1CC Syringe (1ml), Others), By Disease (Type 1 Diabetes, Type 2 Diabetes), By End-User (Hospitals & Clinics, Homecare Settings, Others).

An Introduction to Insulin Syringes Market in 2024

The Insulin Syringes Market comprises disposable syringes designed for accurate insulin dosage measurement and subcutaneous injection in patients with diabetes mellitus. These syringes are available in various sizes, needle gauges, and needle lengths to accommodate different insulin doses and patient preferences. Innovations in insulin syringes focus on needle safety features, ease of handling, dose markings visibility, and compatibility with insulin vials, ensuring precise insulin delivery, minimal wastage, and optimal diabetes care outcomes for patients.

Insulin Syringes Market Competitive Landscape

The global Insulin Syringes Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Insulin Syringes Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Insulin Syringes Industry include- AdvaCare Pharma, ASP Healthcare Pty Ltd, Avantor Inc, B. Braun SE, Becton Dickinson and Co., Cardinal Health Inc, CODAN Medizinische Gerate GmbH and Co KG, Gerresheimer AG, Healthwarehouse.com Inc, Hindustan Syringes and Medical Devices Ltd, Hi-Tech Medics Pvt Ltd, LAC Healthcare Solutions, Nipro Corp, Novo Nordisk A/S, Poly Medicure Ltd, SCHOTT AG, Smiths Group Plc, Terumo Corp, Thermo Fisher S.

Insulin Syringes Market Trend: Shift towards Safety-engineered Insulin Syringes

Safety-engineered insulin syringes are becoming increasingly prominent in the market due to heightened emphasis on healthcare worker safety and infection control. These syringes feature integrated safety mechanisms to prevent needlestick injuries and reduce the risk of bloodborne infections, aligning with regulatory mandates and industry best practices.

Insulin Syringes Market Driver: Increasing Prevalence of Diabetes and Insulin Therapy

The growing prevalence of diabetes globally is a major driver of the insulin syringes market. As the number of individuals requiring insulin therapy rises, there is a parallel increase in the demand for insulin syringes. This driver underscores the significance of insulin syringes as essential tools in diabetes management and highlights the need for reliable, accurate, and user-friendly devices to administer insulin effectively.

Insulin Syringes Market Opportunity: Expansion into Emerging Markets and Adoption of Disposable Syringes

An opportunity exists in expanding into emerging markets where access to insulin syringes may be limited. By addressing affordability, availability, and education, manufacturers can tap into underserved regions and increase market penetration. Additionally, there is potential for growth in the adoption of disposable insulin syringes, driven by convenience, hygiene, and the need to minimize infection risk, presenting opportunities for product innovation and market expansion.

Insulin Syringes Market Share Analysis: 3/10 CC Syringe (0.3ml) is the fastest growing market segment over the forecast period to 2030

Within the category of insulin syringes, the segment experiencing the fastest growth is the 3/10 CC syringe (0.3ml). These syringes are particularly favored for their precise measurement capability, making them ideal for administering insulin doses in smaller increments, which is often necessary for patients with diabetes who require precise dosing adjustments. With advancements in diabetes management and treatment, there is a growing recognition of the importance of personalized insulin dosing to achieve optimal glycemic control and minimize the risk of hypoglycemia. Consequently, healthcare providers are increasingly recommending smaller insulin syringe sizes, such as the 3/10 CC syringe, to accommodate the diverse insulin dosing needs of patients with diabetes. Additionally, the rising prevalence of diabetes globally, particularly type 2 diabetes, has contributed to the increasing demand for insulin syringes, especially in homecare settings where patients self-administer insulin injections. As healthcare providers and patients alike recognize the benefits of precise insulin dosing and self-management, the 3/10 CC syringe segment is poised for continued rapid growth in the insulin syringes market.

Insulin Syringes Market Segmentation

By Syringe Size
3/10 CC Syringe (0.3ml)
1/2 CC Syringe (0.5ml)
1CC Syringe (1ml)
Others
By Disease
Type 1 Diabetes
Type 2 Diabetes
By End-User
Hospitals & Clinics
Homecare Settings
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Insulin Syringes Companies

AdvaCare Pharma
ASP Healthcare Pty Ltd
Avantor Inc
B. Braun SE
Becton Dickinson and Co.
Cardinal Health Inc
CODAN Medizinische Gerate GmbH and Co KG
Gerresheimer AG
Healthwarehouse.com Inc
Hindustan Syringes and Medical Devices Ltd
Hi-Tech Medics Pvt Ltd
LAC Healthcare Solutions
Nipro Corp
Novo Nordisk A/S
Poly Medicure Ltd
SCHOTT AG
Smiths Group Plc
Terumo Corp
Thermo Fisher S
* List not Exhaustive

Reasons to Buy the Insulin Syringes Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Insulin Syringes Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Insulin Syringes Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Insulin Syringes Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Insulin Syringes Market Size Outlook, $ Million, 2021 to 2030
3.2 Insulin Syringes Market Outlook by Type, $ Million, 2021 to 2030
3.3 Insulin Syringes Market Outlook by Product, $ Million, 2021 to 2030
3.4 Insulin Syringes Market Outlook by Application, $ Million, 2021 to 2030
3.5 Insulin Syringes Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Insulin Syringes Industry
4.2 Key Market Trends in Insulin Syringes Industry
4.3 Potential Opportunities in Insulin Syringes Industry
4.4 Key Challenges in Insulin Syringes Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Insulin Syringes Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Insulin Syringes Market Outlook by Segments
7.1 Insulin Syringes Market Outlook by Segments, $ Million, 2021- 2030
By Syringe Size
3/10 CC Syringe (0.3ml)
1/2 CC Syringe (0.5ml)
1CC Syringe (1ml)
Others
By Disease
Type 1 Diabetes
Type 2 Diabetes
By End-User
Hospitals & Clinics
Homecare Settings
Others
8 North America Insulin Syringes Market Analysis and Outlook To 2030
8.1 Introduction to North America Insulin Syringes Markets in 2024
8.2 North America Insulin Syringes Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Insulin Syringes Market size Outlook by Segments, 2021-2030
By Syringe Size
3/10 CC Syringe (0.3ml)
1/2 CC Syringe (0.5ml)
1CC Syringe (1ml)
Others
By Disease
Type 1 Diabetes
Type 2 Diabetes
By End-User
Hospitals & Clinics
Homecare Settings
Others
9 Europe Insulin Syringes Market Analysis and Outlook To 2030
9.1 Introduction to Europe Insulin Syringes Markets in 2024
9.2 Europe Insulin Syringes Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Insulin Syringes Market Size Outlook by Segments, 2021-2030
By Syringe Size
3/10 CC Syringe (0.3ml)
1/2 CC Syringe (0.5ml)
1CC Syringe (1ml)
Others
By Disease
Type 1 Diabetes
Type 2 Diabetes
By End-User
Hospitals & Clinics
Homecare Settings
Others
10 Asia Pacific Insulin Syringes Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Insulin Syringes Markets in 2024
10.2 Asia Pacific Insulin Syringes Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Insulin Syringes Market size Outlook by Segments, 2021-2030
By Syringe Size
3/10 CC Syringe (0.3ml)
1/2 CC Syringe (0.5ml)
1CC Syringe (1ml)
Others
By Disease
Type 1 Diabetes
Type 2 Diabetes
By End-User
Hospitals & Clinics
Homecare Settings
Others
11 South America Insulin Syringes Market Analysis and Outlook To 2030
11.1 Introduction to South America Insulin Syringes Markets in 2024
11.2 South America Insulin Syringes Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Insulin Syringes Market size Outlook by Segments, 2021-2030
By Syringe Size
3/10 CC Syringe (0.3ml)
1/2 CC Syringe (0.5ml)
1CC Syringe (1ml)
Others
By Disease
Type 1 Diabetes
Type 2 Diabetes
By End-User
Hospitals & Clinics
Homecare Settings
Others
12 Middle East and Africa Insulin Syringes Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Insulin Syringes Markets in 2024
12.2 Middle East and Africa Insulin Syringes Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Insulin Syringes Market size Outlook by Segments, 2021-2030
By Syringe Size
3/10 CC Syringe (0.3ml)
1/2 CC Syringe (0.5ml)
1CC Syringe (1ml)
Others
By Disease
Type 1 Diabetes
Type 2 Diabetes
By End-User
Hospitals & Clinics
Homecare Settings
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
AdvaCare Pharma
ASP Healthcare Pty Ltd
Avantor Inc
B. Braun SE
Becton Dickinson and Co.
Cardinal Health Inc
CODAN Medizinische Gerate GmbH and Co KG
Gerresheimer AG
Healthwarehouse.com Inc
Hindustan Syringes and Medical Devices Ltd
Hi-Tech Medics Pvt Ltd
LAC Healthcare Solutions
Nipro Corp
Novo Nordisk A/S
Poly Medicure Ltd
SCHOTT AG
Smiths Group Plc
Terumo Corp
Thermo Fisher S
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Syringe Size
3/10 CC Syringe (0.3ml)
1/2 CC Syringe (0.5ml)
1CC Syringe (1ml)
Others
By Disease
Type 1 Diabetes
Type 2 Diabetes
By End-User
Hospitals & Clinics
Homecare Settings
Others